Rothschild & Co Wealth Management (UK)’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Rothschild & Co Wealth Management (UK)’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,419	Closed	-$37K	–	40
2021 Q3	$37K	Hold	1,419	–	–	﹤0.01%	36
2021 Q2	$20K	Hold	1,419	–	–	﹤0.01%	39
2021 Q1	$15K	Hold	1,419	–	–	﹤0.01%	40
2020 Q4	$11K	Hold	1,419	–	–	﹤0.01%	41
2020 Q3	$11K	Hold	1,419	–	–	﹤0.01%	41
2020 Q2	$13K	Hold	1,419	–	–	﹤0.01%	40
2020 Q1	$14K	Buy	+1,419	New	+$17K	﹤0.01%	39

Other funds holding OPNT

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Rothschild & Co Wealth Management (UK)'s OPNT Position: Q4 2021 in Review

Rothschild & Co Wealth Management (UK) sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q4 2021, closing a stake of 1,419 shares — an estimated $37K sold.

Rothschild & Co Wealth Management (UK) first reported a position in OPNT in Q1 2020 and held it in 7 quarters. The position peaked at $37K in Q3 2021. 42 funds tracked by Wall St. Rank hold OPNT as of Q4 2021.

Rothschild & Co Wealth Management (UK) reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Rothschild & Co Wealth Management (UK) sold 1,419 Opiant Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $37K.
Rothschild & Co Wealth Management (UK) first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 7 quarters.
Rothschild & Co Wealth Management (UK)'s Opiant Pharmaceuticals, Inc. Common Stock position peaked at $37K in Q3 2021.
42 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Rothschild & Co Wealth Management (UK)'s 13F filing for Q4 2021, filed 1 Feb 2022.